Noseda G
Ospedale Beata Vergine, Mendrisio.
Ther Umsch. 1990 Jun;47(6):499-508.
The working panel of the Swiss Foundation for Cardiology has elaborated in 1989 new directives for the treatment of hyperlipaemias. Cholesterol values over 6.5 mmol/l with a cholesterol/HDL ratio over 5 and, in case of coronary heart disease, cholesterol values over 5.2 mmol/l should first be treated by diet. If after 3-6 months, in spite of dietary treatment, cholesterol values remain superior to 6.5 mmol/l or the cholesterol/HDL ratio superior to 6.5, drug treatment must be considered in case of coronary heart disease or arteriosclerosis, considerably abnormal lipid values (cholesterol greater than 7.8 mmol/l; in case of coronary heart disease: cholesterol greater than 6.5 mmol/l), other risk factors, positive family history for coronary heart disease and younger men. Most of the medicaments available today reduce total cholesterol by 10-30%. Combined therapies can be indicated, if in the presence of high risks the different possibilities of monotherapy have not led to the desired success.
瑞士心脏病学基金会工作小组于1989年制定了高脂蛋白血症治疗新指南。胆固醇值超过6.5 mmol/l且胆固醇/高密度脂蛋白比值超过5时,以及患有冠心病时胆固醇值超过5.2 mmol/l,应首先采用饮食治疗。如果经过3至6个月,尽管进行了饮食治疗,胆固醇值仍高于6.5 mmol/l或胆固醇/高密度脂蛋白比值高于6.5,对于冠心病或动脉硬化、脂质值明显异常(胆固醇大于7.8 mmol/l;对于冠心病:胆固醇大于6.5 mmol/l)、其他风险因素、有冠心病家族史的男性以及年轻男性,必须考虑药物治疗。目前可用的大多数药物可使总胆固醇降低10%至30%。如果在高风险情况下单一疗法的不同可能性未取得预期效果,则可采用联合疗法。